Antidepressant-related microstructural changes in the external capsule

• Published in: Brain imaging and behavior 2024-10, Vol.18 (5), p.1044-1051
• Main Authors: Kerpel, Ariel, Davenport, Elizabeth, Proskovec, Amy L., Xi, Yin, Berry, Jarett D., Yetkin, Zerrin, Maldjian, Joseph, Yu, Fang F.
• Format: Article
• Language: English
• Subjects: Adult; Antidepressants; Antidepressive Agents - pharmacology; Antidepressive Agents - therapeutic use; Arteriosclerosis; Atherosclerosis; Biomarkers; Biomedical and Life Sciences; Biomedicine; Brain - diagnostic imaging; Brain - drug effects; Cardiovascular diseases; Case-Control Studies; Density; Ethnic factors; Female; Humans; Inhibitors; Magnetic resonance imaging; Magnetic Resonance Imaging - methods; Male; Medical imaging; Microstructure; Middle Aged; Neurites - drug effects; Neuroimaging; Neuropsychology; Neuroradiology; Neurosciences; Norepinephrine; Orientation; Population studies; Psychiatry; Regression analysis; Risk factors; Selective Serotonin Reuptake Inhibitors - pharmacology; Selective Serotonin Reuptake Inhibitors - therapeutic use; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors - pharmacology; Serotonin and Noradrenaline Reuptake Inhibitors - therapeutic use; Serotonin uptake inhibitors; Sex; Substantia alba; White Matter - diagnostic imaging; White Matter - drug effects
• ISSN: 1931-7565; 1931-7557; 1931-7565
• DOI: 10.1007/s11682-024-00891-w

Several magnetic resonance imaging (MRI) studies have reported that antidepressant medications are strongly linked to brain microstructural alterations. Notably, external capsule alterations have been reported to be a biological marker for therapeutic response. However, prior studies did not investigate whether a change in the neurite density or directional coherence of white matter (WM) fibers underlies the observed microstructural alterations. This MRI-based case–control study examined the relationship between patients’ current use of antidepressant medications and advanced measurements of external capsule WM microstructure derived from multishell diffusion imaging using neurite orientation dispersion and density imaging (NODDI). The study compared a group of thirty-five participants who were taking antidepressant medications comprising selective serotonin reuptake inhibitors (SSRIs) ( n  = 25) and serotonin and norepinephrine reuptake inhibitors (SNRIs) with a control group of thirty-five individuals matched in terms of age, sex, race, and atherosclerotic cardiovascular risk factors. All participants were selected from the Dallas Heart Study phase 2, a multi-ethnic, population-based cohort study. A series of multiple linear regression analyses were conducted to predict microstructural characteristics of the bilateral external capsule using age, sex, and antidepressant medications as predictor variables. There was significantly reduced neurite density in the bilateral external capsules of patients taking SSRIs. Increased orientation dispersion in the external capsule was predominantly seen in patients taking SNRIs. Our findings suggest an association between specific external capsule microstructural changes and antidepressant medications, including reduced neurite density for SSRIs and increased orientation dispersion for SNRIs.